Radiotherapy for breast cancer

Comment

Ian Kunkler. N Engl J Med. 2002.

. 2002 Mar 14;346(11):862-4.

No abstract available

Comment on

Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation.
Bartelink H, Horiot JC, Poortmans P, Struikmans H, Van den Bogaert W, Barillot I, Fourquet A, Borger J, Jager J, Hoogenraad W, Collette L, Pierart M; European Organization for Research and Treatment of Cancer Radiotherapy and Breast Cancer Groups. Bartelink H, et al. N Engl J Med. 2001 Nov 8;345(19):1378-87. doi: 10.1056/NEJMoa010874. N Engl J Med. 2001. PMID: 11794170 Clinical Trial.

Radiation therapy for breast cancer.
Roukos DH. Roukos DH. N Engl J Med. 2009 Mar 26;360(13):1362; author reply 1363. N Engl J Med. 2009. PMID: 19330940 No abstract available.
Radiotherapy for breast cancer in BRCA1/BRCA2 carriers: clinical issues and management dilemmas.
Pierce L. Pierce L. Semin Radiat Oncol. 2002 Oct;12(4):352-61. doi: 10.1053/srao.2002.35254. Semin Radiat Oncol. 2002. PMID: 12382193 Review.
The BRCA1/BRCA2/Rad51 complex is a prognostic and predictive factor in early breast cancer.
Söderlund K, Skoog L, Fornander T, Askmalm MS. Söderlund K, et al. Radiother Oncol. 2007 Sep;84(3):242-51. doi: 10.1016/j.radonc.2007.06.012. Epub 2007 Aug 17. Radiother Oncol. 2007. PMID: 17707537 Clinical Trial.
Ten-year multi-institutional results of breast-conserving surgery and radiotherapy in BRCA1/2-associated stage I/II breast cancer.
Pierce LJ, Levin AM, Rebbeck TR, Ben-David MA, Friedman E, Solin LJ, Harris EE, Gaffney DK, Haffty BG, Dawson LA, Narod SA, Olivotto IA, Eisen A, Whelan TJ, Olopade OI, Isaacs C, Merajver SD, Wong JS, Garber JE, Weber BL. Pierce LJ, et al. J Clin Oncol. 2006 Jun 1;24(16):2437-43. doi: 10.1200/JCO.2005.02.7888. Epub 2006 Apr 24. J Clin Oncol. 2006. PMID: 16636335
Can genetic testing guide treatment in breast cancer?
Tutt A, Ashworth A. Tutt A, et al. Eur J Cancer. 2008 Dec;44(18):2774-80. doi: 10.1016/j.ejca.2008.10.009. Epub 2008 Nov 20. Eur J Cancer. 2008. PMID: 19027287 Review.

LncRNA FGD5-AS1 Facilitates the Radioresistance of Breast Cancer Cells by Enhancing MACC1 Expression Through Competitively Sponging miR-497-5p.
Li J, Lei C, Chen B, Zhu Q. Li J, et al. Front Oncol. 2021 Jun 18;11:671853. doi: 10.3389/fonc.2021.671853. eCollection 2021. Front Oncol. 2021. PMID: 34221989 Free PMC article.